Title: Medical Educator
Company: UAB School of Medicine
Location: Birmingham, Alabama, United States
J. Claude Bennett, Medical Educator at UAB School of Medicine, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in medical education.
Dr. Bennett holds a particular place with the University of Alabama at Birmingham as the university’s fourth president and the 1992 William and the Evalina Chair in Medical Science Leadership. He is well known as the former president and chief operating officer of BioCryst Pharmaceuticals from 1997 to 2008, where the rheumatologist found his expertise needed with the firm’s large autoimmune disease treatment arm. He continues to consult for BioCryst, which creates crystal proteins for X-ray analysis. He is involved with And PNT Therapeutics; cancer therapy for head and neck cancer patients. Dr. Bennett is best known for the delineation of constant and variable regions of immunoglobulin molecules based on peptide analyses of myeloma proteins, as well as a general hypothesis for the generation of antibody diversity. His clinical research opened the door to studying the relationships of infectious agents as initiators of the rheumatoid process.
Born to Claude Bennett and Clara Lucille Bennett as a son of Birmingham, Alabama, Dr. Bennett attended Samford University and completed an MD with Harvard University in 1958. He went home to serve his internship and residency with the UAB Health System before accepting fellowships with the Massachusetts General Hospital in Rheumatology and the National Institutes of Health in molecular biology. Dr. Bennett rejoined the faculty at Birmingham and was named professor and chair of the department of microbiology, as well as director of the division of clinical immunology and rheumatology. From 1977 to 1984, he led the Multipurpose Arthritis Center as director, and dedicated his life to the study of rheumatology. Dr. Bennett was honored as a distinguished faculty lecturer by the UAB School of Medicine in 1979, and led the university from 1993 to 1997. That year, he joined the board of trustees for the university and was named Distinguished University Professor Emeritus.
After his notable tenure with the University of Alabama at Birmingham, Dr. Bennett turned to the private sector with BioCryst Pharmaceuticals. Then still a young company, the successful firm now designs and develops small-molecule drugs for rare diseases, including influenza, hereditary angioedema, and a broad treatment for multiple viruses. In addition to his leadership with BioCryst, Dr. Bennett has served on many scientific advisory boards, published a plethora of medical articles, and maintained membership with the American Academy of Microbiology, the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Royal Society of Medicine, London, as well as honorary membership with the Ludwig Heilmeyer Society in Germany. He was presented honorary degrees from the University of Alabama at Birmingham, the University of Leipzig in Germany, and the University of Zurich in Switzerland. Dr. Bennett is the holder of numerous awards, most recently the 2000 Kober Medal from the Association of American Physicians and the 2000 Carol Nachman Medal from the German Society of Rheumatology.
Contact Dr. Bennett